Medical terminology · Neurology
Gangliosidoses, GM2
MeSH — National Library of Medicine · Retrieved 2026-10-13
A group of recessively inherited diseases characterized by the intralysosomal accumulation of G(M2) GANGLIOSIDE in the neuronal cells. Subtypes include mutations of enzymes in the BETA-N-ACETYLHEXOSAMINIDASES system or G(M2) ACTIVATOR PROTEIN leading to disruption of normal degradation of GANGLIOSIDES, a subclass of ACIDIC GLYCOSPHINGOLIPIDS.
Reference details
- MeSH descriptor
- D020143
- Vocabulary edition
- 2026
- Tree positions
- C10.228.140.163.100.435.825.300.300; C16.320.565.189.435.825.300.300; C16.320.565.398.641.803.350.300; C16.320.565.595.554.825.300.300; C18.452.132.100.435.825.300.300; C18.452.584.563.641.803.350.300; C18.452.648.189.435.825.300.300; C18.452.648.398.641.803.350.300; C18.452.648.595.554.825.300.300
Scope and definition
Entry terms and synonyms
Classification tree positions
Sources and reuse
Medical vocabulary definition and classification record.
Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.
Courtesy of the U.S. National Library of Medicine. DrugChat is independent and is not endorsed by NLM.